Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
Wednesday, December 07, 2022Pfizer Inc and Clear Creek Bio Inc today announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the SARSCoV papainlike protease PLpro for the oral treatment of COVID PLpr...
RedHill's Aemcolo® Granted FDA QIDP 5-Year Exclusivity Extension
Tuesday, December 06, 2022RedHill Biopharma Ltd a specialty biopharmaceutical company today announced that the US Food and Drug Administrations FDA Exclusivity Board has granted Aemcolo five years exclusivity under the Generating Antibiotic Incentives Now GAIN Act Qualified I...
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
Tuesday, December 06, 2022Solid Biosciences Inc a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy Duchenne today announced the closing of its acquisition of AavantiBio a privately held gene therapy company focused on transformin...
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
Saturday, December 03, 2022Immunocore Holdings plc a commercialstage biotechnology company pioneering the development of a novel class of T cell receptor TCR bispecific immunotherapies designed to treat a broad range of diseases including cancer autoimmune and infectious disea...
Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
Friday, December 02, 2022Solid Biosciences Inc a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy Duchenne today announced the results of the special meeting of the stockholders held on December At the special meeting Solids s...
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Friday, December 02, 2022Rocket Pharmaceuticals Inc a leading latestage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need today announces that it has completed the previously announce...
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
Thursday, December 01, 2022BioNTech SE and Ryvu Therapeutics SA a clinicalstage company developing oncology therapeutics today announced that the companies have entered into a multitarget research collaboration for several small molecule immunotherapy programs as well as an ex...
Argenx Enters Into Agreement To Acquire Priority Review Voucher
Thursday, December 01, 2022Argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases today announced an agreement to acquire a US Food and Drug Administration FDA Priority Review Voucher PRV for million A PRV en...
Envisagenics Announces Research Collaboration with Bristol Myers Squibb
Wednesday, November 30, 2022Envisagenics an Artificial Intelligence AIdriven biotechnology company that delivers therapies for RNA splicing diseases today announced a research collaboration agreement with Bristol Myers Squibb The multiyear collaboration will leverage Envisageni...
Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
Wednesday, November 30, 2022Ribon Therapeutics a clinical stage biotechnology company developing therapeutics targeting stress support pathways today announced that it entered into an agreement on the acquisition of its CD program with Boehringer Ingelheim This includes a small...
